rs2230798
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003640.5(ELP1):c.2855A>T(p.Lys952Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0178 in 1,613,514 control chromosomes in the GnomAD database, including 365 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K952Q) has been classified as Uncertain significance.
Frequency
Consequence
NM_003640.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ELP1 | NM_003640.5 | c.2855A>T | p.Lys952Ile | missense_variant | 26/37 | ENST00000374647.10 | |
ELP1 | NM_001318360.2 | c.2513A>T | p.Lys838Ile | missense_variant | 26/37 | ||
ELP1 | NM_001330749.2 | c.1808A>T | p.Lys603Ile | missense_variant | 24/35 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ELP1 | ENST00000374647.10 | c.2855A>T | p.Lys952Ile | missense_variant | 26/37 | 1 | NM_003640.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.0136 AC: 2075AN: 152162Hom.: 15 Cov.: 32
GnomAD3 exomes AF: 0.0157 AC: 3954AN: 251192Hom.: 49 AF XY: 0.0152 AC XY: 2060AN XY: 135746
GnomAD4 exome AF: 0.0182 AC: 26614AN: 1461234Hom.: 350 Cov.: 30 AF XY: 0.0177 AC XY: 12874AN XY: 726932
GnomAD4 genome ? AF: 0.0136 AC: 2072AN: 152280Hom.: 15 Cov.: 32 AF XY: 0.0135 AC XY: 1004AN XY: 74478
ClinVar
Submissions by phenotype
not specified Benign:3
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 22, 2019 | Variant summary: IKBKAP c.2855A>T (p.Lys952Ile) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.016 in 276918 control chromosomes in the gnomAD database, including 53 homozygotes. The observed variant frequency is approximately 8.5 fold of the estimated maximal expected allele frequency for a pathogenic variant in IKBKAP causing Familial Dysautonomia phenotype (0.0018), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.2855A>T in individuals affected with Familial Dysautonomia and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as benign. Based on the evidence outlined above, the variant was classified as benign. - |
Familial dysautonomia Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Oct 09, 2014 | - - |
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 30, 2018 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 28, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at